Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a specific type of blood cancer called AML (Acute Myeloid Leukemia, but not a subtype called APL), based on the 2022 WHO diagnostic standards, and who have not yet received major anti-leukemia treatment (some limited pre-treatments to reduce cell counts may be acceptable)
- People aged 18 or older
- People whose general health and ability to function falls within a certain range, as measured by a standard medical scoring system called the ECOG scale (score of 4 or below) (confirm with trial site)
- Women who are able to become pregnant and agree to use effective contraception during treatment and for at least 3 months after treatment ends, and all participants must sign a consent form agreeing to take part
Who may not be able to join:
- People with a known allergy to the study drugs being tested
- People whose leukemia has already stopped responding to the drugs azacitidine or venetoclax
- People who are unable to swallow and take oral (by mouth) medications
- People who have an active infection (bacterial, fungal, or viral) that is not under control
- People who have serious problems with major organs that are not under control, such as heart failure, severe liver failure, or moderate to severe kidney failure
- People who are already taking part in another clinical trial that could interfere with this one, or anyone the medical team considers unsuitable for participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianyu Weng, Guangdong Provincial People Hosptial
Phone: 020-83827812
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite complete remission (CRc)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.